Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 4538
116th Congress(2019-2020)
Closing Loopholes for Orphan Drugs Act
Introduced
Introduced
Introduced in House on Sep 26, 2019
Overview
Text
Introduced in House 
Sep 26, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Sep 26, 2019)
Sep 26, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 4538 (Introduced-in-House)


116th CONGRESS
1st Session
H. R. 4538


To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.

IN THE HOUSE OF REPRESENTATIVES

September 26, 2019

Mr. Welch (for himself and Mr. McKinley) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Closing Loopholes for Orphan Drugs Act”.

SEC. 2. Limiting the orphan drug exclusion under 340B drug discount program.

(a) In general.—Section 340B(e) of the Public Health Service Act (42 U.S.C. 256b(e)) is amended by inserting before the period at the end the following: “when transferred, prescribed, sold, or otherwise used for the rare condition or disease for which such drug is so designated”.

(b) Effective date.—The amendment made by subsection (a) shall apply with respect to covered outpatient drugs purchased on or after the date of the enactment of this Act.